| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |